Local Storage seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Local Storage in your browser.
HY-50 17 mg/ml 3 ml
HY-50 17 mg/ml 3 ml
Sodium hyaluronate 17 mg/ml. Pre-loaded 3 ml single-dose glass syringes.
For intra-articular and intravenous treatment of lameness caused by joint dysfunction associated with non-infectious synovitis. Do not use in cases of joint infection.
Transient mild swelling and/or heat has been reported in treated joints (2.7%). These self-limiting local signs resolve spontaneously within48 hours, and do not negate a successful therapeutic outcome.
|Registration number||REG NL 10541|
|Active Ingredient||Hyaluronic acid|
|Legal status of supply||UDD|
|Withdrawal period||0 days|
|Expiry date||Jul 31, 2022|
|Units per outer box||1|
Instructions for use
Dosage and administration route
Intravenous use: 3 ml intravenously repeatedat weekly intervals for a total of three treatments.
For single intra-articular injection: 3 ml (51 mg) intra-articularly into medium sized and large joints. Smaller joints such as intertarsal, tarsometatarsal and interphalangeal joints can be treated with a 1.5 ml dose (25.5 mg). More than one joint may be treated at the same time.
Excess synovial ﬂuid should be removed whenever possible prior to injection. Remove product from refrigerator approximately 10 minutes before performing injection.
The injection should be administered under strict aseptic conditions. Ensure removal of dirt, hair, topical medicaments and soap/antiseptic residues.
Intra-articular injections should not be made through overlying skin that is infected, blistered, scurfed or otherwise compromised. A sterile dressing and clean bandage should be applied after injection, as appropriate for the particular joint treated.
Single dose syringes made ready for injection shall be used immediately. Any unused portion of a syringeis to be discarded.